Regulatory landscape

Approved in Russia, unapproved in the West

Semax occupies an unusual regulatory position: a prescription medicine in Russia, and an unapproved research chemical across the West. Understanding why explains a lot about the whole evidence picture.

This unit maps where Semax is approved, traces its approval history, details its unapproved status in the US, EU, UK, and Australia, and explains the regulatory gap without pretending it means the drug is either safe or unsafe.